Karyopharm Therapeutics: Spiraling Despite Upcoming Catalysts

5d ago, source:

Karyopharm Therapeutics Inc.'s selinexor is making waves at ASCO, with potential benefits in myelofibrosis. Click here to ...

Karyopharm Therapeutics Inc. (KPTI)

6d ago, source: Yahoo Finance

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that several abstracts detailing new selinexor data have ...

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4d ago, source:

The vesting of each RSU award is subject to the employee's continued service as an employee of, or other service provider to, ...

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting

12d ago, source: Stockhouse

April 24, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that several abstracts ...

Japan Pet Cancer Therapeutics Market: Forecasted to Reach US$26.1 Million by 2031

2d ago, source: Taiwan News

Some of the major players in the Japan pet cancer therapeutics market are Boehringer Ingelheim International GmbH, Zoetis Inc., AB Science, Elanco Animal Health Incorporated, ELIAS Animal Health LLC, ...

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q1 2024 Earnings Call Transcript

on MSN ago, source:

Q1 2024 Earnings Call Transcript May 3, 2024 Kymera Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge ...

KPTI Karyopharm Therapeutics Inc.

1mon ago, source: Seeking Alpha

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other ...

Karyopharm Therapeutics Inc (KPTI)

3d ago, source: Investing

Karyopharm Therapeutics (NASDAQ:KPTI) has conducted its Fourth Quarter and Full Year 2023 Financial Results Conference Call, highlighting its financial status and progress in ...

Karyopharm Therapeutics Inc (KPTI)

3d ago, source: Investing

Shares of Forty Seven, Inc. (NASDAQ:FTSV) jumped 61.9% after the Gilead Sciences (NASDAQ:GILD) said it plans to buy the cancer therapy companyShares of Mobile Mini, Inc. ...

Karyopharm Therapeutics Inc KPTI

13d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Karyopharm Therapeutics Inc.

21d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Karyopharm Therapeutics Inc

19d ago, source: U.S. News & World Report

Invest with your heart and your phone with as little as $1 with these ESG and socially responsible investing apps.